
Inborn errors of neurotransmitter, BH4 and folate metabolism are treatable disorders. Without therapy they lead to early onset movement disorders. Immediate diagnosis and treatment initiation result in an improved outcome. This course is aimed at clinicians with a basic knowledge of inborn errors of neurotransmitter, pterin and folate metabolisms who are working a metabolic or child neurology clinic. Both adult and childhood disease will be covered so it is suitable for practitioners in both areas.
This course is intended to be interactive; it brings together a vast array of know-how, experts and resources to improve participants understanding of IEM in order to promote best practice in hospitals and healthcare systems.
Participants will be encouraged to provide abstracts for case presentations.
LEARNING OBJECTIVES
- Learn about the clinical presentation of inborn errors of neurotransmitter, BH4 and folate metabolism.
- Understanding of biochemical pathways related to the disorders.
- Awareness of the critical issues and pitfalls in the diagnostic work-up and treatment of these diseases.
- Awareness of the benefits and limitations of classical treatment concepts and understanding of novel and future therapeutic strategies.
PROVIDER ORGANISATION
This course is organised in joint collaboration between the University Hospital for Childhood and Adolescent Medicine of Heidelberg and the University Hospital of Padua. The course will be held on the San Servolo Island in cooperation with the Venice International University.
UNIVERSITY HOSPITAL FOR CHILDHOOD AND ADOLESCENT MEDICINE, HEIDELBERG
The University Hospital for Childhood and Adolescent Medicine in Heidelberg has a long-standing tradition and reputation in the field of inborn errors of metabolism, especially neuro-metabolic disorders. At present, more than 400 patients with inborn errors of metabolism are followed and treated. There exists a professional team of physicians and scientists, nurses, dieticians, psychologists and social workers with specific experience in the field of inborn errors of metabolism. The hospital is equipped with a separate ward for patients with metabolic and endocrinological problems, a huge outpatient clinic, a new-born screening laboratory, various research facilities, and one of the largest laboratories for the biochemical and molecular diagnosis of nearly all inborn metabolic diseases serving physicians and institutions from all over Germany.
UNIVERSITY HOSPITAL PADUA
The Division of Metabolic Disorders at the department of Paediatrics is part of the General Hospital of Padua providing healthcare services counting 8,412 hospital and 4,086 day hospital admissions. Within the Department of Paediatrics is the Division providing extensive services for families and children with metabolic disease. The University Hospital is involved in teaching and research activities, especially clinical and translational research, postgraduate programmes and continuing medical education courses. Research in the metabolic disease area includes:
- Epidemiological studies applying new neonatal screening methods to assess the frequency of some diseases that develop acutely in the new-born.
- Organic acid disorders and laboratory methods to identify new disorders.
- Carbohydrate disorders, description of a new disease with hyperinsulinaemia and hyperammonaemia.
- Disorders of cerebral neurotransmitters.
Scientifc Organising Committee
- Dr Thomas Opladen, University Hospital for Childhood and Adolescent Medicine, Heidelberg
- Prof Stefan Kölker, University Hospital for Childhood and Adolescent Medicine, Heidelberg
- Prof Georg Hoffmann, University Hospital for Childhood and Adolescent Medicine, Heidelberg
- Prof Alberto Burlina, University Hospital Padua
- Dr Angels Garcia, Sant Joan de Déu Hospital, Barcelona
Contact RRD Foundation
Cecilia Kellquist
Recordati Rare Diseases Fondation d'entreprise
Immeuble ‘Le Wilson’
70 avenue du Général de Gaulle
92800 PUTEAUX, France
Telephone : +33 1 47 73 86 11
Fax : +33 1 49 00 18 00
Email : ckellquist@rrd-foundation.org